Advisory Research Inc Novo Cure LTD Transaction History

Advisory Research Inc

$512 Million
Q3 2024

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 16, 2022	BUY	$60.15 - $84.52 $110,375 - $155,094	1,835 Added 60.01%	4,893 $405,000
Q4 2021 Feb 11, 2022	SELL	$75.08 - $121.99 $603,342 - $980,311	-8,036 Reduced 72.44%	3,058 $230,000
Q3 2021 Nov 12, 2021	SELL	$116.17 - $194.55 $818,533 - $1.37 Million	-7,046 Reduced 38.84%	11,094 $1.29 Million
Q2 2021 Aug 16, 2021	SELL	$130.4 - $225.58 $85,672 - $148,206	-657 Reduced 3.5%	18,140 $4.02 Million
Q1 2021 May 12, 2021	SELL	$124.11 - $190.17 $845,437 - $1.3 Million	-6,812 Reduced 26.6%	18,797 $2.49 Million
Q4 2020 Feb 12, 2021	SELL	$112.16 - $174.14 $1.83 Million - $2.85 Million	-16,347 Reduced 38.96%	25,609 $4.43 Million
Q3 2020 Nov 12, 2020	BUY	$58.05 - $111.31 $498,301 - $955,485	8,584 Added 25.72%	41,956 $4.67 Million
Q2 2020 Aug 13, 2020	SELL	$57.2 - $74.41 $225,024 - $292,728	-3,934 Reduced 10.55%	33,372 $1.98 Million
Q1 2020 May 12, 2020	SELL	$57.05 - $95.75 $188,949 - $317,124	-3,312 Reduced 8.15%	37,306 $2.51 Million
Q4 2019 Feb 11, 2020	BUY	$68.3 - $93.8 $1.03 Million - $1.42 Million	15,094 Added 59.14%	40,618 $3.42 Million
Q3 2019 Nov 12, 2019	SELL	$61.86 - $97.8 $3.05 Million - $4.82 Million	-49,237 Reduced 65.86%	25,524 $1.91 Million
Q2 2019 Aug 14, 2019	BUY	$42.22 - $63.23 $521,163 - $780,511	12,344 Added 19.78%	74,761 $4.73 Million
Q1 2019 May 15, 2019	SELL	$31.96 - $56.12 $119,562 - $209,944	-3,741 Reduced 5.65%	62,417 $3.01 Million
Q4 2018 Feb 13, 2019	SELL	$28.72 - $52.63 $784,458 - $1.44 Million	-27,314 Reduced 29.22%	66,158 $2.22 Million
Q3 2018 Nov 13, 2018	SELL	$32.0 - $52.4 $1.32 Million - $2.16 Million	-41,238 Reduced 30.61%	93,472 $4.9 Million
Q2 2018 Aug 14, 2018	BUY	$19.85 - $32.0 $365,240 - $588,800	18,400 Added 15.82%	134,710 $4.22 Million
Q1 2018 May 15, 2018	BUY	$19.3 - $23.65 $241,269 - $295,648	12,501 Added 12.04%	116,310 $2.54 Million
Q4 2017 Feb 08, 2018	SELL	$16.3 - $21.9 $122,250 - $164,250	-7,500 Reduced 6.74%	103,809 $2.1 Million
Q3 2017 Nov 14, 2017	BUY	$18.05 - $21.75 $2.01 Million - $2.42 Million	111,309	111,309 $2.21 Million

Others Institutions Holding NVCR

# of Institutions

263

Shares Held

77M

Call Options Held

1.17M

Put Options Held

318K

Black Rock Inc. New York, NY

12.1M
Shares

$389 Million
0.0% of portfolio
Vanguard Group Inc Valley Forge, PA

11.8M
Shares

$380 Million
0.0% of portfolio
Capital International Investors Los Angeles, CA

7.92M
Shares

$254 Million
0.02% of portfolio
Capital World Investors Los Angeles, CA

4.31M
Shares

$138 Million
0.01% of portfolio
Nordwand Advisors, LLC Radnor, PA

3.03M
Shares

$97.3 Million
12.67% of portfolio

View Full List

About NovoCure Ltd

Ticker NVCR
Exchange NASDAQ
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 104,950,000
Market Cap $3.37B
Description
NovoCure Limited, an oncology company, engages in the development, manufacture, and commercialization of tumor treating fields (TTFields) devices for the treatment of solid tumor cancers in the United States, Europe, the Middle East, Africa, Japan, and Greater China. Its TTFields devices include Optune for the treatment of glioblastoma; and Optu...

More about NVCR

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Advisory Research Inc, based on Form 13F filings with the SEC.

News

Stay updated on Advisory Research Inc with notifications on news.

Account